Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...